Africa: Oxford R21/Matrix-MTM malaria vaccine receives World Health Organization recommendation for use paving the way for global roll-out
[Oxford University] The highly effective vaccine developed by the University of Oxford and the Serum Institute of India, leveraging Novavax's adjuvant is critical to reducing over half a million malaria-related deaths annually.
Source: AllAfrica News: Malaria - Category: Infectious Diseases Tags: Africa Asia, Australia, and Africa Children and Youth Europe and Africa External Relations Health and Medicine Malaria Science and Biotechnology Source Type: news
More News: African Health | Australia Health | Biotechnology | Children | India Health | Infectious Diseases | International Medicine & Public Health | Malaria | Malaria Vaccine | Oxford University | Science | Vaccines | WHO